Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Illumina HiSeq 3000 (Homo sapiens)
Patient 34 tumor
SRA Run Selector
Patient 30 tumor
Patient 35 tumor
Patient 31 tumor
Patient 29 tumor
Patient 24 tumor
Patient 22 tumor
Patient 21 tumor
Patient 20 tumor
Patient 17 tumor
Patient 15 tumor
Patient 14 tumor
Patient 11 tumor
Patient 10 tumor
Patient 2 tumor
Patient 33 tumor
Patient 28 tumor
Patient 27 tumor
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on